Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors
Neal I. Lindeman(Brigham and Women's Hospital), Philip T. Cagle(Methodist Hospital), Dara L. Aisner(University of Colorado Denver), Maria E. Arcila(Memorial Sloan Kettering Cancer Center), Mary Beth Beasley(Pulmonary and Critical Care Associates), Eric Bernicker(Methodist Hospital), Carol Colasacco(College of American Pathologists), Sanja Đačić(University of Pittsburgh), Fred R. Hirsch(University of Colorado Denver), Keith M. Kerr(University of Aberdeen), David J. Kwiatkowski(Brigham and Women's Hospital), Marc Ladanyi(Memorial Sloan Kettering Cancer Center), Jan A. Nowak(Roswell Park Comprehensive Cancer Center), Lynette M. Sholl(Brigham and Women's Hospital), Robyn Temple‐Smolkin, Benjamin Solomon(Peter MacCallum Cancer Centre), Lesley Souter, Erik Thunnissen(Amsterdam UMC Location Vrije Universiteit Amsterdam), Ming‐Sound Tsao(Princess Margaret Cancer Centre), Christina B. Ventura(College of American Pathologists), Murry W. Wynes(International Association for the Study of Lung Cancer), Yasushi Yatabe(Aichi Cancer Center)
Cited by 631Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis